MBC APPROVALpdf

M/S MBC INDUSTRIES, TRILOKPUR ROAD, KALA-AMB, TEHSIL- NAHAN, DISTT-SIRMOUR (HP) 173030 UNDER
DRUGS MANUFACTURING LICENSE NO. N-MNB/17/186 & N-MB/17/187 RETAINED UPTO 08/05/2027.
Sr. Ph. Approval
Generic Name Composition Strength
No. Ref. Date
Each Film Coated Tablets Contains:
Atorvastatin Calcium IP
Atorvastatin Tablets IP Eq. to Atorvastatin 10 mg 09.05.2017
Excipients q.s.
Colour: Approved colour used
Each Uncoated Tablets Contains:
Aceclofenac IP 100 mg
Aceclofenac &
1. Paracetamol IP 325 mg 09.05.2017
Paracetamol Tablets
Excipients q.s.
2. Atorvastatin Tablets IP Eq. to Atorvastatin 20 mg 09.05.2017
Excipients q.s.
3. Aceclofenac Tablets IP 09.05.2017
Excipients q.s.
Each Uncoated Sustained Release Tablets
Contains:
Aceclofenac (SR)
4. Aceclofenac IP 200 mg 09.05.2017
Tablets
Excipients q.s.
Paracetamol IP 500 mg
5. Paracetamol Tablets IP 09.05.2017
Excipients q.s.

6. Paracetamol Tablets IP 09.05.2017
Excipients q.s.
Each Enteric Coated Tablets Contains:

Rabeprazole Sodium Rabeprazole Sodium IP 20 mg
7. 09.05.2017
Tablets IP Excipients q.s.
Pantoprazole Sodium IP
Pantoprazole Gastro-
8. Eq. to Pantoprazole 40 mg 09.05.2017
resistant Tablets IP
Excipients q.s.
Amisulpride IP 100 mg
9. Amisulpride Tablets IP Excipients q.s. 09.05.2017


Sr. Ph. Approval
No. Ref. Date
Aceclofenac &
Thiocolchicoside IP 8 mg
12. Thiocolchicoside 09.05.2017
Excipients q.s.
Tablets

Aceclofenac &
Thiocolchicoside IP 4 mg
13. Thiocolchicoside 09.05.2017
Excipients q.s.
Tablets

Etoricoxib IP 90 mg
14. Etoricoxib Tablets IP Excipients q.s. 09.05.2017

Olanzapine IP 2.5 mg
15. Olanzapine Tablets IP 09.05.2017
Excipients q.s.
Olanzapine IP 5 mg
Excipients q.s.
Olanzapine IP 7.5 mg
Excipients q.s.
Olanzapine IP 10 mg
Excipients q.s.
Etizolam 0.5 mg
19. Etizolam Tablets 09.05.2017
Excipients q.s.
Haloperidol IP 5 mg
20. Haloperidol Tablets IP 09.05.2017
Excipients q.s.
Etizolam 0.25 mg 09.05.2017
21. Etizolam Tablets
Excipients q.s.
Paracetamol & Domperidone IP 20 mg
22. 09.05.2017
Domperidone Tablets Excipients q.s.

Esomeprazole Magnisium Trihydrate IP
Esomeprazole Tablets
23. Eq. to Esomeprazole 40 mg 09.05.2017
IP
Excipients q.s.
Sr. Ph. Approval
No. Ref. Date
Each Uncoated Bilayered Tablets Contains:
Glimepiride IP 1 mg
Glimepiride &
Metformin Hydrochloride IP 1000 mg
Metformin
24. (as sustained release) 09.05.2017
Hydrochloride (SR)
Excipients q.s.
Tablets

Glimepiride IP 2 mg
Glimepiride &
Metformin
25. (as sustained release) 09.05.2017
Hydrochloride (SR)
Excipients q.s.
Tablets
Each Hard Gelatin Capsule Contains:

Rabeprazole Sodium IP 20 mg
(As enteric coated pellets)
Enteric Coated
Levosulpride IP 75 mg
Rabeprazole Sodium &
26. (as sustained release pellets) 09.05.2017
Levosulpride Sustained
Excipients q.s.
Release Capsules
Approved colour used in empty capsule shell
& Pellets

Enteric Coated (As enteric coated pellets)
Rabeprazole Sodium & Domperidone IP 30 mg
27. Domperidone (as sustained release pellets) 09.05.2017
Sustained Release Excipients q.s.
Capsules Approved colour used in empty capsule shell
& Pellets

Omeprazole IP 20 mg
Omeprazole &
Domperidone IP 30 mg
28. Domperidone Capsules 09.05.2017
(as Sustain release Pellets)
IP
Excipients q.s.
& Pellets
Pregabalin IP 75 mg
Pregabalin &
Methylcobalamin IP 750 mcg
29. Methylcobalamin 09.05.2017
Excipients
Capsules IP
Approved colour used in empty capsule shell q.s.
& Pellets
Mecobalamin IP 1000 mcg
Alpha Lipoic Acid USP 200 mg
Mecobalamin, Alpha
Folic Acid IP 1500 mcg
Lipoic Acid, Folic Acid,
Vitamin B6 IP 3 mg 09.05.2017
30. Vitamin B6,
Benfotiamine 100 mg
Benfotiamine & Inositol
Inositol USP 100 mg
Capsules
Excipients q.s.
& Pellets
Sr. Ph. Approval
No. Ref. Date
Omeprazole IP 20 mg
Omeprazole &
31. Domperidone Capsules 09.05.2017
(as Sustain release Pellets)
IP
Excipients q.s.
& Pellets
Sertraline Sertraline Hydrochloride IP
32. Hydrochloride Tablets Eq. to Sertraline 25 mg 12.05.2017
IP Excipients q.s.
IP Excipients q.s.
IP Excipients q.s.
Fluconazole IP 150 mg
35. Fluconazole Tablets IP 12.05.2017
Excipients q.s.
Fluconazole IP 200 mg
36. Fluconazole Tablets IP 12.05.2017
Excipients q.s.
Amlodipine Besylate IP
37. Amlodipine Tablets IP Eq. to Amlodipine 5 mg 12.05.2017
Excipients q.s.
38. Amlodipine Tablets IP Eq. to Amlodipine 10 mg 12.05.2017
Excipients q.s.
Metformin Metformin Hydrochloride IP 500 mg
Hydrochloride (as prolonged-release) 12.05.2017
39.
Prolonged-release & Glimepiride IP 1 mg
Glimepiride Tablets IP Excipients q.s.
Baclofen IP 10 mg
40. Baclofen Tablets IP 12.05.2017
Excipients q.s.
Metformin
Hydrochloride 12.05.2017
41. (as prolonged-release)
Prolonged-release &
Glimepiride IP 2 mg
Glimepiride Tablets IP
Excipients q.s.
Sr. Ph. Approval
No. Ref. Date
Ferrous Ascorbate
Eq. to Elemental Iron 100 mg
Ferrous Ascorbate,
Folic Acid IP 1.5 mg
42. Folic Acid & Zinc 12.05.2017
Zinc Sulphate Monohydrate IP
Sulphate Tablets
Eq. to Elemental Zinc 22.5 mg
Excipients q.s.
Ferrous Ascorbate
Ferrous Ascorbate & Eq. to Elemental Iron 100 mg 12.05.2017
43.
Folic Acid Tablets Folic Acid IP 1.5 mg
Excipients q.s.
Ferrous Ascorbate
Ferrous Ascorbate,
Folic Acid,
44. Methylcobalamin IP 1.5 mg 12.05.2017
Methylcobalamin &
Zinc Sulphate Tablets
Excipients q.s.
Telmisartan IP 20 mg
45. Telmisartan Tablets IP 12.05.2017
Excipients q.s.
Excipients q.s.
Excipients q.s.
Aceclofenac & Paracetamol IP 325 mg 12.05.2017
48.
Paracetamol Tablets Excipients q.s.

Calcium Carbonate IP
Eq. to elemental Calcium 500 mg 1250 mg
Calcium Carbonate & 12.05.2017
49. Vitamin D3 IP 250 IU
Vitamin D3 Tablets IP
Excipients q.s.

Pregabalin IP 150 mg
Pregabalin & Methylcobalamin IP 750 mcg
50. Methylcobalamin Excipients 12.05.2017
Capsules IP Approved colour used in empty capsule shell q.s.
& Pellets
Sr. Ph. Approval
No. Ref. Date
Each hard gelatin capsule contains:
Pantoprazole Gastro- Eq. to Pantoprazole 40 mg
Resistant & (As gastro-resistant pellets)
51. Domperidone Domperidone IP 30 mg 12.05.2017
Prolonged-Release (As sustained release pellets)
Capsules IP Excipients q.s.
Colour: Approved colour used in empty
capsule shells & pellets
Fluoxetine Fluoxetine Hydrochloride IP
52. Hydrochloride Tablets Eq. to Fluoxetine 10 mg 12.05.2017
IP Excipients q.s.
Fluoxetine Fluoxetine Hydrochloride IP
53. Hydrochloride Tablets Eq. to Fluoxetine 20 mg 12.05.2017
IP Excipients q.s.
Amitriptyline Hydrochloride IP 10 mg
54. Amitriptyline Tablets IP 12.05.2017
Excipients q.s.
Excipients q.s.
Excipients q.s.
Pregabalin IP 75 mg
Pregabalin & Nortriptyline Hydrochloride IP
57. 12.05.2017
Nortriptyline Tablets Eq. to Nortriptyline 10 mg
Excipients q.s.
Mecobalamin, Alpha
Thiamine Mononitrate IP 10 mg
Lipoic Acid, Folic Acid, 12.05.2017
58. Pyridoxine Hydrochloride IP 3 mg
Vitamin B6 & Thiamine
Mononitrate Capsule
Excipients q.s.
Tramadol Tramadol Hydrochloride IP 37.5 mg
59. Hydrochloride & Paracetamol IP 325 mg 12.05.2017
Excipients q.s.
Sr. Ph. Approval
No. Ref. Date
Excipients q.s.
Atorvastatin & Eq. to Atorvastatin 10 mg
62. 22.05.2017
Fenofibrate Tablets Fenofibrate IP 80 mg
Excipients q.s.
Atorvastatin & Eq. to Atorvastatin 10 mg 22.05.2017
63.
Excipients q.s.
Atorvastatin & Eq. to Atorvastatin 10 mg
64. 22.05.2017
Excipients q.s.
Telmisartan & Telmisartan IP 40 mg
65. Hydrochlorothiazide Hydrochlorothiazide IP 12.5 mg 22.05.2017
Telmisartan & Telmisartan IP 80 mg
Rosuvastatin Calcium IP
Rosuvastatin Tablets
67. Eq. to Rosuvastatin 10 mg 22.05.2017
IP
Excipients q.s.
Rosuvastatin Tablets 22.05.2017
68. Eq. to Rosuvastatin 20 mg
IP
Excipients q.s.
Rosuvastatin & Eq. to Rosuvastatin 20 mg
69. 22.05.2017
Excipients q.s.
Levocetirizine Hydrochloride IP 5 mg
Montelukast Sodium &
Montelukast Sodium IP
Levocetirizine
70. Eq. to Montelukast 10 mg 22.05.2017
Hydrochloride Tablets
Excipients q.s.
IP
Sr. Ph. Approval
No. Ref. Date
Levocetirizine Tablets Levocetirizine Hydrochloride IP 5 mg 22.05.2017
71.
IP Excipients q.s.
Nimesulide BP 100 mg
Nimesulide &
Paracetamol Tablets
Excipients q.s.
Each Uncoated Dispersible Tablets Contains:
Levocetirizine Hydrochloride
Levocetirizine 22.05.2017
73. Excipients IP 5 mg
Dispersible Tablets
Colour: Approved colour used q.s.
Each Uncoated Dispersible Tablets Contains:

Levocetirizine Hydrochloride
Levocetirizine 22.05.2017
74. Excipients IP 10 mg
Dispersible Tablets

75. Amisulpride Tablets IP 22.05.2017
Excipients q.s.
Aripiprazole IP 10 mg
76. Aripiprazole Tablets IP 22.05.2017
Excipients q.s.
Aripiprazole IP 15 mg 22.05.2017
77. Aripiprazole Tablets IP
Excipients q.s.
Baclofen IP 20 mg
Excipients q.s.
Citalopram Hydrobromide IP
79. Citalopram Tablets IP Eq. to Citalopram 40 mg 22.05.2017
Excipients q.s.
Each Uncoated Chewable Tablets Contains:
Fexofenadine Hydrochloride
Fexofenadine Montelukast Sodium IP 120 mg
80. Hydrochloride & Eq. to Montelukast IP 22.05.2017
Montelukast Tablets Excipients 10 mg

Ramipril IP 2.5 mg
81. Ramipril Tablets IP 22.05.2017
Excipients q.s.
Ramipril IP 5 mg
82. Ramipril Tablets IP Excipients q.s. 22.05.2017
Sr. Ph. Approval
No. Ref. Date
Ramipril IP 10 mg 22.05.2017
83. Ramipril Tablets IP
Excipients q.s.
Etoricoxib IP 60 mg
84. Etoricoxib Tablets IP 22.05.2017
Excipients q.s.
Ebastin IP 10 mg
85. Ebastin Tablets IP 22.05.2017
Excipients q.s.
Ebastin IP 20 mg 22.05.2017
86. Ebastin Tablets IP
Excipients q.s.
Hydroxyzine Hydrochloride IP 25 mg
87. Hydroxyzine Tablets IP 22.05.2017
Excipients q.s.
Hydroxyzine Hydrochloride IP 10 mg
88. Hydroxyzine Tablets IP 22.05.2017
Excipients q.s.
Propranolol
Propranolol Hydrochloride IP 10 mg
89. Hydrochloride 22.05.2017
Excipients q.s.
Tablets IP
Propranolol
Propranolol Hydrochloride IP 40 mg 22.05.2017
90. Hydrochloride
Excipients q.s.
Tablets IP
Oxcarbazepine Tablets Oxcarbazepine IP 300 mg
91. 22.05.2017
IP Excipients q.s.
92. 22.05.2017
IP Excipients q.s.
93. 22.05.2017
IP Excipients q.s.
Each Film Coated Prolonged-release Tablets
Contains:
Divalproex Prolonged- Divalproex Sodium IP 22.05.2017
94.
release Tablets IP Eq. to Valproic Acid 250 mg
Excipients q.s.
Contains:
Divalproex Prolonged- Divalproex Sodium IP 500 mg
95. 22.05.2017
release Tablets IP Eq. to Valproic Acid q.s.
Excipients
Sr. Ph. Approval
No. Ref. Date
Contains:
96. 22.05.2017
Excipients
Contains:
97. 22.05.2017
Excipients
Each Film Coated Controlled-Release
Tablets Contains:
Sodium Valproate and Sodium Valproate IP 333 mg
Valproic Acid Valproic Acid IP 145 mg
98. 22.05.2017
Controlled-Release um (Both Corresponding to Sodium Valproate
Valproate Tablets 500 mg)
Excipients q.s.
Tablets Contains:
Sodium Valproate and Sodium Valproate IP 133.5 mg
99. 22.05.2017
Excipients q.s.
Tablets Contains:
100. 22.05.2017
Excipients q.s.
Tablets Contains:
Valproic Acid Valproic Acid IP 290 mg 22.05.2017
101.
Excipients q.s.
Tablets Contains:
Sodium Valproate and Sodium Valproate IP 499.5 mg
Valproic Acid Valproic Acid IP 217.5 mg
102. 22.05.2017
Excipients q.s.
Sodium Valproate Sodium Valproate IP 100 mg
103. 22.05.2017
Sr. Ph. Approval
No. Ref. Date
Sodium Valproate Sodium Valproate IP 200 mg 22.05.2017
104.
Haloperidol IP 10 mg
Excipients q.s.
Haloperidol IP 1.5 mg
Excipients q.s.
Quetiapine Fumarate IP
107. Quetiapine Tablets IP Eq. to Quetiapine 25 mg 22.05.2017
Excipients q.s.
Excipients q.s.
Excipients q.s.
Excipients q.s.
Each Uncoated Prolonged-release Tablets
Lithium Carbonate Contains:
111. Prolonged-release Lithium Carbonate IP 400 mg 22.05.2017
Lithium Carbonate Lithium Carbonate IP 300 mg
114. 22.05.2017
Methylprednisolone IP 16 mg
Methylprednisolone
115. Excipients q.s. 22.05.2017
Tablets IP
Sr. Ph. Approval
No. Ref. Date
Clomipramine Clomipramine Hydrochloride IP 25 mg 22.05.2017
116.
Hydrochloride Tablets Excipients q.s.
Clomipramine Clomipramine Hydrochloride IP 10 mg
117. 22.05.2017
118. Mecobalamin Tablets 22.05.2017
Excipients q.s.
Nimesulide BP 100 mg 22.05.2017
119. Nimesulide Tablets
Excipients q.s.
Glimepiride IP 1 mg
120. Glimepiride Tablets IP 22.05.2017
Excipients q.s.
Glimepiride IP 2 mg
121. Glimepiride Tablets IP 22.05.2017
Excipients q.s.
Cinnarizine IP 20 mg
122. Cinnarizine Tablets IP 22.05.2017
Excipients q.s.
Cinnarizine IP 20 mg
Cinnarizine &
123. Domperidone IP 15 mg 22.05.2017
Domperidone Tablets
Excipients q.s.
Each Uncoated Chewable Tablet Contains:
Albendazole IP 400 mg
124. Albendazole Tablets IP 25.05.2017
Excipients
Losartan Potassium Losartan Potassium IP 50 mg
125. 25.05.2017
Losartan Potassium & Losartan Potassium IP 50 mg
Tablets Excipients q.s.
Clopidogrel Bisulphate IP
Clopidogrel Bisulphate
127. Eq. to Clopidogrel 75 mg 25.05.2017
Tablets IP
Excipients q.s.
Doxofylline IP 400 mg
128. Doxofylline Tablets IP Excipients q.s. 25.05.2017
Sr. Ph. Approval
No. Ref. Date
Olmesartan Medoxomil Olmesartan Medoxomil IP 20 mg 25.05.2017
129.
Olmesartan Medoxomil Olmesartan Medoxomil IP 40 mg
130. 25.05.2017
Each Film Coated Prolonged-release Tablet
Contains:
Metoprolol Prolonged- Metoprolol Succinate IP 25 mg
131. 25.05.2017
release Tablets IP Eq. to Metoprolol Tartrate q.s.
Excipients
Contains:
Metoprolol Prolonged- Metoprolol Succinate IP 50 mg
132. 25.05.2017
release Tablets IP Eq. to Metoprolol Tartrate q.s.
Excipients
Levetiracetam Tablets Levetiracetam IP 500 mg
133. 25.05.2017
IP Excipients q.s.
Deflazacort 30 mg
134. Deflazacort Tablets 25.05.2017
Excipients q.s.
Deflazacort 6 mg
135. Deflazacort Tablets 25.05.2017
Excipients q.s.
Risperidone BP 4 mg
136. Risperidone Tablets 25.05.2017
Excipients q.s.
Risperidone BP 2 mg
Excipients q.s.
Paroxetine Hydrochloride IP 10 mg
138. Paroxetine Tablets IP Eq. to Paroxetine q.s. 25.05.2017
Excipients
Excipients
Excipients
141. Paroxetine Tablets Each Film Coated Tablets Contains: 25.05.2017
Sr. Ph. Approval
No. Ref. Date
Paroxetine Hydrochloride IP 12.5 mg
Eq. to Paroxetine q.s.
Excipients
142. Paroxetine Tablets Eq. to Paroxetine q.s. 25.05.2017
Excipients
Flunarizine Flunarizine Dihydrochloride BP 10 mg
143. Dihydrochloride Eq. to Flunarizine q.s. 25.05.2017
Tablets Excipients
Procyclidine Hydrochloride IP 5 mg
144. Procyclidine Tablets IP 25.05.2017
Excipients q.s.
Procyclidine Hydrochloride IP 2.5 mg
145. Procyclidine Tablets IP 25.05.2017
Excipients q.s.
Gabapentin IP 100 mg
146. Gabapentin Tablets IP 25.05.2017
Excipients q.s.
Bisoprolol Fumarate Bisoprolol Fumarate USP 5 mg
147. 25.05.2017
Tablets USP Excipients q.s.
Bisoprolol Fumarate Bisoprolol Fumarate USP 2.5 mg
148. 25.05.2017
Disulfiram IP 200 mg
149. Disulfiram Tablets IP Excipients q.s. 25.05.2017

Nebivolol Hydrochloride IP 5 mg
Eq. to Nebivolol q.s. 25.05.2017
150. Nebivolol Tablets IP
Excipients

Acarbose IP 100 mg
151. Acarbose Tablets IP Excipients q.s. 25.05.2017

Acarbose IP 50 mg
152. Acarbose Tablets IP Excipients q.s. 25.05.2017
153. Omeprazole Gastro- Each hard gelatin capsule contains: 25.05.2017

Sr. Ph. Approval
No. Ref. Date
resistant Capsules IP Omeprazole IP 20 mg
(As Gastro-resistant pellets)
Excipients q.s.
Mirtazapine IP 7.5 mg
154. Mirtazapine Tablets IP 25.05.2017
Excipients q.s.
Risperidone BP 3 mg
Excipients q.s.
Risperidone BP 1 mg 25.05.2017
156. Risperidone Tablets
Excipients q.s.
Each Enteric Coated Tablet Contains:
Diclofenac Potassium BP 50 mg
Diclofenac Potassium Serratiopeptidase IP 10 mg
157. & Serratiopeptidase (As enteric coated granules eq. to 20000 25.05.2017
Tablets units Enzymeatic activity)
Excipients q.s.
Mefenamic Acid &
Mefenamic Acid IP 250 mg
Dicyclomine
158. Dicyclomine Hydrochloride IP 10 mg 25.05.2017
Excipients q.s.
IP
Aceclofenac & Aceclofenac IP 100 mg
159. Drotaverine Drotaverine Hydrochloride IP 80 mg 25.05.2017
Diacerin IP 50 mg
Diacerin & Aceclofenac
160. Aceclofenac IP 100 mg 25.05.2017
Tablets
Excipients q.s.
Lornoxicam 4 mg
Lornoxicam & 25.05.2017
161. Paracetamol IP 325 mg
Paracetamol Tablets
Excipients q.s.
Olmesartan Medoxomil Olmesartan Medoxomil IP 20 mg
162. & Hydrochlorothiazide Hydrochlorothiazide IP 12.5 mg 25.05.2017
Olmesartan Medoxomil IP 40 mg
Olmesartan Medoxomil
Hydrochlorothiazide IP 12.5 mg
163. & Hydrochlorothiazide 25.05.2017
Excipients q.s.
Tablets IP
164. Olmesartan Medoxomil Each Film Coated Tablets Contains: 25.05.2017

Sr. Ph. Approval
No. Ref. Date
& Hydrochlorothiazide Olmesartan Medoxomil IP 40 mg
Tablets IP Hydrochlorothiazide IP 25 mg
Excipients q.s.
Each Film Coated Tablet Contains:
Aceclofenac, Paracetamol IP 325 mg
Paracetamol & Serratiopeptidase IP 10 mg
165. 25.05.2017
Serratiopeptidase (As Enteric coated granules eq to 20000
Excipients q.s.
Aceclofenac, Paracetamol IP 325 mg
Paracetamol & Serratiopeptidase IP 15 mg
166. 25.05.2017
Serratiopeptidase (As Enteric coated granules eq to 30000
Excipients q.s.
Clopidogrel Bisulphate IP
Aspirin & Clopidogrel Eq. to Clopidogrel 150 mg
167. 25.05.2017
Bisulphate Tablets Aspirin IP 75 mg
Excipients q.s.
Lornoxicam 8 mg
Lornoxicam &
Paracetamol Tablets
Excipients q.s.
Etodolac IP 300 mg
Etodolac &
Paracetamol Tablets
Excipients q.s.
Etodolac IP 400 mg
Etodolac &
Paracetamol Tablets
Excipients q.s.
Each Uncoated Tablet Contains:
Paracetamol, Paracetamol IP 325 mg
Phenylephrine, Phenylephrine Hydrochloride IP 5 mg
171. Caffeine and Caffeine (Anhydrous) IP 30 mg 25.05.2017
Diphenhydramine Diphenhydramine Hydrochloride IP 25 mg
Hydrochloride Tablets Excipients
Fluoxetine Hydrochloride IP
Fluoxetine Eq. to Fluoxetine 20 mg
172. Hydrochloride & Olanzapine IP 5 mg 25.05.2017
Olanzapine Tablets Excipients q.s.
173. Citicoline Sodium & Each Film Coated Tablet Contains: 25.05.2017
Sr. Ph. Approval
No. Ref. Date
Piracetam Tablets Citicoline Sodium IP
Eq. to Citicoline 500 mg
Piracetam IP 400 mg
Excipients q.s.
Dosulepine
Dosulepine Hydrochloride IP 50 mg
Hydrochloride &
174. Methylcobalmin IP 1500 mcg 25.05.2017
Methylcobalmin
Excipients q.s.
Tablets
Dosulepine
Dosulepine Hydrochloride IP 75 mg
Hydrochloride &
175. Methylcobalmin IP 1500 mcg 25.05.2017
Methylcobalmin
Excipients q.s.
Tablets
Mecobalamin, Methylcobalmin IP 750 mcg
Pyridoxine Pyridoxine Hydrochloride IP 1.5 mg
176. 25.05.2017
Hydrochloride & Nicotinamide IP 45 mg
Nicotinamide Tablets Excipients q.s.
Aceclofenac &
Tizanidine Hydrochloride IP
177. Tizanidine 25.05.2017
Eq. to TizanidineNicotinamide 2 mg
Excipients q.s.
Aspirin IP 150 mg
Aspirin & Clopidogrel Clopidogrel Bisulphate IP
178. 25.05.2017
Bisulphate Tablets Eq. to Clopidogrel 300 mg
Excipients q.s.
Mefenamic Acid IP 500 mg
Mefenamic Acid &
179. Tizanidine 25.05.2017
Eq. to Tizanidine 2 mg
Excipients q.s.
Diclofenac Potassium, Paracetamol IP 325 mg
Paracetamol & Serratiopeptidase 10 mg 25.05.2017
180.
Serratiopeptidase (As Enteric coated granules eq. to 20000
Excipients q.s.
Diclofenac Potassium, Paracetamol IP 325 mg
Paracetamol & Serratiopeptidase 15 mg
181. 25.05.2017
Serratiopeptidase (As Enteric coated granules eq. to 30000
Excipients q.s.
182. Diclofenac Potassium Each Film Coated Tablet Contains: 27.05.2017
Sr. Ph. Approval
No. Ref. Date
and Chlorzoxazone Diclofenac Potassium BP 50 mg
Tablets Chlorzoxazone USP 250 mg
Excipients q.s.
Each Uncoated Sustained-release Tablet
Propranolol Contains:
183. Hydrochloride (SR) Propranolol Hydrochloride IP 40 mg 27.05.2017
Propranolol Contains:
184. Hydrochloride (SR) Propranolol Hydrochloride IP 80 mg 27.05.2017
Amlodipine and Eq. to Amlodipine 5 mg
185. 27.05.2017
Atenolol Tablets Atenolol IP 50 mg
Excipients q.s.
Losartan Potassium IP 50 mg
Losartan Potassium
186. Atenolol IP 50 mg 27.05.2017
and Atenolol Tablets
Excipients q.s.
187. Olmesartan Medoxomil Olmesartan Medoxomil IP 20 mg 27.05.2017

188. Losratan Potassium Losratan Potassium IP 50 mg 27.05.2017

Eq. to Amlodipine 5 mg
Amlodipine and
Atorvastatin Calcium IP 27.05.2017
189. Atorvastatin Calcium
Eq. to Atorvastatin 10 mg
Tablets
Excipients q.s.

Amlodipine and
190. Atorvastatin Calcium 27.05.2017
Tablets
Excipients q.s.
191. Amlodipine and Each Film Coated Tablet Contains: 27.05.2017

Sr. Ph. Approval
No. Ref. Date
Atorvastatin Calcium Amlodipine Besylate IP
Tablets Eq. to Amlodipine 10 mg
Excipients q.s.
Amlodipine and
192. Bisoprolol Fumarate 27.05.2017
Bisoprolol Fumarate USP 5 mg
Tablets
Excipients q.s.
Amlodipine and Metoprolol Succinate IP
193. 27.05.2017
Metoprolol Tablets Eq. to Metoprolol Tartrate 50 mg
Excipients q.s.


Amlodipine and
Nebivolol Hydrochloride IP
195. Nebivolol 27.05.2017
Eq. to Nebivolol 5 mg
Excipients q.s.

196. Nebivolol Nebivolol Hydrochloride IP 27.05.2017
Hydrochloride Tablets Eq. to Nebivolol 5 mg
Excipients q.s.
Telmisartan and Amlodipine Besylate IP
197. 27.05.2017
Amlodipine Tablets IP Eq. to Amlodipine 5 mg
Excipients q.s.
Nebivolol Hydrochloride IP
Nebivolol
Eq. to Nebivolol 5 mg
Hydrochloride and 27.05.2017
198. Hydrochlorothiazide IP 12.5 mg
Hydrochlorothiazide
Excipients q.s.
Tablets
199. Amlodipine and Each Uncoated Tablet Contains: 27.05.2017

Sr. Ph. Approval
No. Ref. Date
Losratan Potassium Amlodipine Besylate IP
Tablets Eq. to Amlodipine 5 mg
Losratan Potassium IP 25 mg
Excipients q.s.
Ciprofloxacin Hydrochloride IP
Ciprofloxacin Tablets
200. Eq. to Ciprofloxacin 250 mg 27.05.2017
IP
Excipients q.s.
IP
Excipients q.s.
IP
Excipients q.s.
Phenobarbitone Phenobarbitone IP 30 mg
203. 27.05.2017
Phenobarbitone Phenobarbitone IP 60 mg
204. 27.05.2017
Fluoxetine
Eq. to Fluoxetine 20 mg
205. Hydrochloride and 27.05.2017
Olanzapine IP 10 mg
Olanzapine Tablets
Excipients q.s.
Methylcobalamin and
206. Gabapentin IP 300 mg 27.05.2017
Gabapentin Tablets
Excipients q.s.
Terbinafine Hydrochloride IP
207. Terbinafine Tablets IP Eq. to Terbinafine 250 mg 27.05.2017
Excipients q.s.
208. Aciclovir Tablets IP Aciclovir IP 200 mg 27.05.2017
Excipients q.s.
Excipients q.s.
Excipients q.s.
211. Folic Acid Tablets IP Folic Acid IP 5 mg 27.05.2017
Excipients q.s.
Sr. Ph. Approval
No. Ref. Date
212. Folic Acid Tablets IP Folic Acid IP 10 mg 27.05.2017
Excipients q.s.
Topiramate IP 25 mg
213. Topiramate Tablets IP 27.05.2017
Excipients q.s.
Topiramate IP 50 mg
Excipients q.s.
Topiramate IP 100 mg 27.05.2017
215. Topiramate Tablets IP
Excipients q.s.
Topiramate IP 200 mg
Excipients q.s.
Excipients q.s.
Excipients q.s.
Mirtazapine IP 30 mg
219. Mirtazapine Tablets IP 27.05.2017
Excipients q.s.
Torsemide IP 10 mg
220. Torsemide Tablets IP 27.05.2017
Excipients q.s.
Ramipril and Ramipril IP 2.5 mg
Thioridazine
Thioridazine Hydrochloride USP 25 mg
222. Hydrochloride Tablets 27.05.2017
Excipients q.s.
USP
Thioridazine
Thioridazine Hydrochloride USP 50 mg 27.05.2017
223. Hydrochloride Tablets
Excipients q.s.
USP
Nicorandil IP 10 mg
224. Nicorandil Tablets IP 27.05.2017
Excipients q.s.
Nicorandil IP 20 mg
225. Nicorandil Tablets IP 27.05.2017
Excipients q.s.
Sr. Ph. Approval
No. Ref. Date
Each Uncoated Prolonged-releaseTablet
Contains:
Nicorandil Prolonged- 27.05.2017
226. Nicorandil IP 20 mg
releaseTablets IP
Excipients q.s.
Each Uncoated Prolonged-releaseTablet
Contains:
Nicorandil Prolonged-
227. Nicorandil IP 10 mg 27.05.2017
releaseTablets IP
Excipients q.s.
Nicorandil IP 5 mg 27.05.2017
228. Nicorandil Tablets IP
Excipients q.s.
Voglibose IP 0.2 mg
229. VogliboseTablets IP 27.05.2017
Excipients q.s.
Voglibose IP 0.3 mg
230. VogliboseTablets IP 27.05.2017
Excipients q.s.
Each Uncoated DispersibleTablet Contains:
Voglibose Dispersible Voglibose IP 0.2 mg
231. 27.05.2017
Voglibose Dispersible Voglibose IP 0.3 mg
232. 27.05.2017
Each Uncoated Bilayered Tablet Contains:
Voglibose IP 0.3 mg
Voglibose & Metformin
233. Hydrochloride (SR) 27.05.2017
(As sustained release) q.s.
Tablets
Excipients
Each Uncoated Bilayered Tablet Contains:
Voglibose IP 0.2 mg
(As sustained release) q.s.
Tablets
Excipients
Tenoxicam BP 20 mg
235. Tenoxicam Tablets Excipients q.s. 27.05.2017

Roxithromycin IP 150 mg
Roxithromycin Tablets
236. Excipients q.s. 27.05.2017
IP

Roxithromycin Tablets Roxithromycin IP 300 mg 27.05.2017
237.
IP Excipients q.s.
Sr. Ph. Approval
No. Ref. Date
Roxithromycin Tablets Roxithromycin IP 75 mg 27.05.2017
238.
(For Paediatric use) Excipients q.s.
Roxithromycin Roxithromycin IP 50 mg
239. 27.05.2017
Dispersible Tablets Excipients q.s.
Ornidazole IP 500 mg
240. Ornidazole Tablets IP 27.05.2017
Excipients q.s.
Ofloxacin IP 200 mg 27.05.2017
241. Ofloxacin Tablets IP
Excipients q.s.
Ofloxacin IP 400 mg
242. Ofloxacin Tablets IP 27.05.2017
Excipients q.s.
Ofloxacin IP 200 mg
Ofloxacin &
243. Ornidazole IP 500 mg 27.05.2017
OrnidazoleTablets IP
Excipients q.s.
Each Gastro-resistant Tablet Contains:
Duloxetine Hydrochloride IP
Duloxetine Gastro-
244. Eq. to Duloxetine 20 mg 27.05.2017
Excipients q.s.
Duloxetine Gastro-
245. Eq. to Duloxetine 30 mg 27.05.2017
Excipients q.s.
Duloxetine Gastro- Eq. to Duloxetine 40 mg
246. 27.05.2017
resistant Tablets IP Excipients q.s.

Duloxetine Gastro- Eq. to Duloxetine 60 mg 27.05.2017
247.
resistant Tablets IP Excipients q.s.

Deflazacort 24 mg
248. Deflazacort Tablets Excipients q.s. 27.05.2017

Pioglitazone Hydrochloride IP 27.05.2017
249. Pioglitazone Tablets IP
Eq. to Pioglitazone 15 mg
Excipients q.s.
Sr. Ph. Approval
No. Ref. Date
Pioglitazone Hydrochloride IP
250. Pioglitazone Tablets IP Eq. to Pioglitazone 30 mg 27.05.2017
Excipients q.s.
251. Pioglitazone Tablets IP Eq. to Pioglitazone 45 mg 27.05.2017
Excipients q.s.
Risperidone and Risperidone BP 3 mg
252. Trihexyphendyl Trihexyphendyl Hydrochloride IP 2 mg 27.05.2017
254. 27.05.2017
Fenofibrate Tablets IP Fenofibrate IP 145 mg
Excipients q.s.
255. 27.05.2017
Excipients q.s.
Levetiracetam Tablets Levetiracetam IP 250 mg
256. 27.05.2017
IP Excipients q.s.
Ciprofloxacin and Eq. to Ciprofloxacin 500 mg
257. 27.05.2017
Ornidazole Tablets Ornidazole IP 500 mg
Excipients q.s.
Levetiracetam Tablets Levetiracetam IP 750 mg 27.05.2017
258.
IP Excipients q.s.
Calcium Citrate Malate
Calcium Citrate Malate Eq. to Calcium 250 mg
259. 27.05.2017
& Vitamin D3 Tablets Vitamin D3 IP 200 IU
Excipients q.s.
Calcium Citrate Malate, Each Film Coated Tablet Contains:
260. Vitamin D3 & Folic Acid Calcium Citrate Malate 27.05.2017
Tablets Eq. to Calcium 250 mg
Sr. Ph. Approval
No. Ref. Date
Vitamin D3 IP 100 IU
Folic Acid IP 50 mcg
Excipients q.s.

Levofloxacin Hemihydrate IP
Eq. to Levofloxacin 250 mg
261. Levofloxacin Tablets IP 27.05.2017
Excipients q.s.

Eq. to Levofloxacin 500 mg 27.05.2017
262. Levofloxacin Tablets IP
Excipients q.s.

Eq. to Levofloxacin 750 mg
263. Levofloxacin Tablets IP
Excipients q.s.

Folic acid IP 5 mg
Vitamin C IP 75 mg
Mecobalamin, Folic
Vitamin B6 IP 10 mg
acid, Vitamin C,
264. Carbonyl Iron 02.06.2017
Vitamin B6, and
Carbonyl Iron Capsules
Excipients q.s.
capsule shells

Flunarizine Dihydrochloride BP
Flunarizine Eq. to Flunarizine 10 mg
Dihydrochloride and Propranolol Hydrochloride IP 40 mg
265. Propranolol (As sustained-release pellets) 02.06.2017
Hydrochloride (SR) Excipients q.s.
Capsules Colour: Approved colour used in empty
capsule shells

Flunarizine Dihydrochloride BP
Flunarizine Eq. to Flunarizine 5 mg
Dihydrochloride and Propranolol Hydrochloride IP 40 mg
266. Propranolol (As sustained-release pellets) 02.06.2017
Hydrochloride (SR) Excipients q.s.
Capsules Colour: Approved colour used in empty
capsule shells
Methylcobalamin, Each hard gelatin capsule contains:

Alpha Lipoic Acid, Folic Methylcobalamin IP 1500 mcg
267. 02.06.2017
Acid, Selenium Alpha Lipoic Acid USP 100 mg
Dioxide, Vitamin B1, Folic Acid IP 1.5 mg
Sr. Ph. Approval
No. Ref. Date
Vitamin B6, Vitamin Selenium Dioxide BP 163.6 mcg
E, Vitamin A, Calcium Pantothenate IP 10 mg
Chromium, Inositol Vitamin B1 IP 10 mg
Capsules Vitamin B6 IP 1.5 mg
Vitamin E Acetate IP 25 IU
Vitamin A Acetate IP 5000 IU
Chromium Polynicotinate USP 200 mcg
Inositol USP 100 mg
Excipients q.s.
capsule shells

Drotaverine Drotaverine Hydrochloride IP 40 mg
268. Hydrochloride Tablets Excipients q.s. 02.06.2017
IP Colour: Approved colour used

Drotaverine Drotaverine Hydrochloride IP 80 mg
269. Hydrochloride Tablets Excipients q.s. 02.06.2017

Norfloxacin IP 400 mg
Norfloxacin & Tinidazole IP 600 mg
270. 02.06.2017
Tinidazole Tablets Excipients q.s.
271.

Contains:
Pregabalin (SR) Pregabalin IP 75 mg 02.06.2017
272.
Each Uncoated chewable Tablet Contains:

Ivermectin IP 6 mg
Ivermectin and Albendazole IP 400 mg
273. 02.06.2017
Albendazole Tablets Excipients q.s.

Calcium Carbonate IP
Calcium, Calcitriol and Eq. to Elemental Calcium 200 mg 02.06.2017
274.
Zinc Tablets Calcitriol IP 0.25 mcg
Sr. Ph. Approval
No. Ref. Date
Excipients q.s.
Gliclazide and Gliclazide IP 80 mg
275. Metformin Metformin Hydrochloride IP 500 mg 02.06.2017
Prednisolone Tablets Prednisolone IP 5 mg
276. 02.06.2017
IP Excipients q.s.
Prednisolone Tablets Prednisolone IP 10 mg 02.06.2017
277.
IP Excipients q.s.
Prednisolone Tablets Prednisolone IP 20 mg
278. 02.06.2017
IP Excipients q.s.
Sildenafil Citrate IP
279. Sildenafil Tablets IP Eq. to Sildenafil 50 mg 02.06.2017
Excipients q.s.
Sildenafil Citrate IP
280. Sildenafil Tablets IP Eq. to Sildenafil 100 mg 02.06.2017
Excipients q.s.
Chlorpromazine
Chlorpromazine hydrochloride IP 200 mg
Hydrochloride and
281. Trihexyphenidyl Hydrochloride IP 2 mg 02.06.2017
Trihexyphenidyl
Excipients q.s.
Clidinium Bromide, Clidinium Bromide USP 2.5 mg
Paracetamol and Paracetamol IP 325 mg
282. 02.06.2017
Dicyclomine Dicyclomine Hydrochloride IP 10 mg
Piracetam IP 400 mg
283. Piracetam Tablets Excipients q.s. 02.06.2017

Piracetam IP 800 mg
284. Piracetam Tablets Excipients q.s. 02.06.2017

Piracetam IP 1200 mg
285. Piracetam Tablets 02.06.2017
Excipients q.s.
Trifluoperazine Each Film Coated Tablet Contains: 02.06.2017
286.
Hydrochloride and Trifluoperazine Hydrochloride IP
Sr. Ph. Approval
No. Ref. Date
Trihexyphenidyl Eq. to Trifluoperazine 10 mg
Hydrochloride Tablets Trihexyphenidyl Hydrochloride IP 2 mg
Excipients q.s.

Imipramine Hydrochloride IP 25 mg
287. Imipramine Tablets IP 02.06.2017
Excipients q.s.
Imipramine Hydrochloride IP 50 mg
288. Imipramine Tablets IP Excipients q.s. 02.06.2017

Chlorpromazine
Chlorpromazine Hydrochloride IP 50 mg
Hydrochloride,
Trifluoperazine Hydrochloride IP
Trifluoperazine
289. Eq. to Trifluoperazine 5 mg 02.06.2017
Hydrochloride and
Trihexyphenidyl Hydrochloride IP 2 mg
Trihexyphenidyl
Excipients q.s.
Chlorpromazine
Chlorpromazine hydrochloride IP 100 mg
Hydrochloride and
290. Trihexyphenidyl Hydrochloride IP 2 mg 02.06.2017
Trihexyphenidyl
Excipients q.s.
Disulfiram IP 500 mg 02.06.2017
291. Disulfiram Tablets IP
Excipients q.s.
Diclofenac Potassium
& Paracetamol Tablets
Excipients q.s.
Escitalopram Oxalate IP
Escitalopram Tablets
293. Eq. to Escitalopram 10 mg 02.06.2017
IP
Excipients q.s.
Escitalopram Tablets 02.06.2017
294. Eq. to Escitalopram 20 mg
IP
Excipients q.s.
Etoricoxib and Thiocolchicoside IP 4 mg
295. Thiocolchicoside Etoricoxib IP 60 mg 02.06.2017
Levocetirizine
Levocetirizine Hydrochloride IP 5 mg
Hydrochloride and
Ambroxol Hydrochloride IP 75 mg 02.06.2017
296. Ambroxol
(in sustained release form)
Hydrochloride (SR)
Excipients q.s.
Tablets
Sr. Ph. Approval
No. Ref. Date
Ciprofloxacin and Eq. to Ciprofloxacin 500 mg
297. 02.06.2017
Tinidazole Tablets Tinidazole IP 600 mg
Excipients q.s.
Trifluoperazine Trifluoperazine Hydrochloride IP
Hydrochloride and Eq. to Trifluoperazine 2.5 mg
298. 02.06.2017
Trihexyphenidyl Trihexyphenidyl Hydrochloride IP 1 mg
Hydrochloride and Eq. to Trifluoperazine 5 mg
300. 02.06.2017
Trihexyphenidyl Trihexyphenidyl Hydrochloride IP 2 mg
Mefenamic Acid, Mefenamic Acid IP 250 mg
Paracetamol & Paracetamol IP 325 mg
301. 02.06.2017
Dicyclomine Dicyclomine Hydrochloride IP 10 mg
Azithromycin Dihydrate IP
Azithromycin Tablets
302. Eq. to Azithromycin 250 mg 02.06.2017
IP
Excipients q.s.
Azithromycin Tablets
303. Eq. to Azithromycin 500 mg 02.06.2017
IP
Excipients q.s.
Flunarizine Flunarizine Dihydrochloride BP
304. Dihydrochloride Eq. to Flunarizine 5 mg 02.06.2017
Each Uncoated Extended-releaseTablet
Contains:
Bupropion
Bupropion Hydrochloride USP 150 mg
305. Hydrochloride (ER) 02.06.2017
Excipients q.s.
Tablets USP
Each Uncoated Extended-releaseTablet

Bupropion Contains:
306. Hydrochloride (ER) Bupropion Hydrochloride USP 300 mg 02.06.2017
307. Pregabalin (SR) and Each Uncoated Tablet Contains: 02.06.2017
Sr. Ph. Approval
No. Ref. Date
Methylcobalmin Pregabalin IP 75 mg
Tablets (As Sustained-release)
Methylcobalmin IP 1500 mcg
Excipients q.s.
Pregabalin (SR) and
(As Sustained-release)
308. Methylcobalmin 02.06.2017
Tablets
Excipients q.s.
Pregabalin (SR) and
(As Sustained-release) 02.06.2017
309. Methylcobalmin
Tablets
Excipients q.s.
Pantoprazole and Eq. to Pantoprazole 40 mg
310. 02.06.2017
Domperidone Tablets Domperidone IP 10 mg
Excipients q.s.
Haloperidol and Haloperidol IP 1.5 mg
311. Trihexyphenidyl Trihexyphenidyl Hydrochloride IP 2 mg 02.06.2017
Haloperidol and Haloperidol IP 5 mg
312. Trihexyphenidyl Trihexyphenidyl Hydrochloride IP 2 mg 02.06.2017
Itraconazole Pellets BP
Itraconazole Capsules Eq. to Itraconazole 100 mg
313. 02.06.2017
BP Excipient q.s.
& pellets
Itraconazole Pellets BP
Itraconazole Capsules Eq. to Itraconazole 200 mg 02.06.2017
314.
BP Excipient q.s.
& pellets
Escitalopram Tablets
315. Eq. to Escitalopram 5 mg 29.06.2017
IP
Excipients q.s.
Serratiopeptidase IP 15 mg 29.06.2017
316. & Serratiopeptidase
(As enteric coated granules eq. to 30000
Tablets
units enzymeatic activity)
Excipients q.s.
Sr. Ph. Approval
No. Ref. Date
Each Uncoated Orally Disintegrating Tablet
Contains:
Ondansetron Orally
Ondansetron Hydrochloride IP
317. Disintegrating Tablets 29.06.2017
Eq. to Ondansetron 4 mg
IP
Excipients q.s.
Betahistine Each Uncoated Tablet Contains:
318. Hydrochloride Tablets Betahistine Hydrochloride IP 8 mg 29.06.2017
IP Excipients q.s.
Betahistine Each Uncoated Tablet Contains:
319. Hydrochloride Tablets Betahistine Hydrochloride IP 16 mg 29.06.2017
IP Excipients q.s.
Rosuvastatin Tablets
320. Eq. to Rosuvastatin 5 mg 29.06.2017
IP
Excipients q.s.
Cetirizine Each Uncoated Tablet Contains:
321. Hydrochloride Tablets Cetirizine Hydrochloride IP 10 mg 29.06.2017
IP Excipients q.s.
Etoricoxib IP 60 mg
Etoricoxib and
Paracetamol Tablets
Excipients q.s.
Citicoline Sodium IP
323. Citicoline Tablets IP Eq. to Citicoline 500 mg 29.06.2017
Excipients q.s.
Tranexamic Acid and Tranexamic Acid IP 500 mg
324. Mefenamic Acid Mefenamic Acid IP 250 mg 29.06.2017
Ramipril IP 5 mg
Ramipril and
325. Telmisartan IP 40 mg 29.06.2017
Telmisartan Tablets
Excipients q.s.
Rabeprazole Sodium IP
Rabeprazole (as enteric coated pellets) 20 mg
Sodium(EC) and Itopride Hydrochloride IP 29.06.2017
326.
Itopride HCl (SR) (as sustain release pellets) 150 mg
Capsules Excipient q.s.
& pellets
Glimepiride IP 1 mg
Glimepiride,
Pioglitazone Hydrochloride IP 15 mg
Pioglitazone &
327. Eq. to Pioglitazone 29.06.2017
Metformin HCl (ER)
Tablets
(As Extended Release)
Excipients q.s.
Sr. Ph. Approval
No. Ref. Date

Glimepiride IP 2 mg
Glimepiride,
Eq. to Pioglitazone
Pioglitazone &
328. Metformin Hydrochloride IP 500 mg 29.06.2017
Metformin HCl (ER)
Tablets
Excipients q.s.

Eperisone Eperisone Hydrochloride 50 mg 29.06.2017
329.
Each Uncoated Dispersible Tablet Contains:
Montelukast Sodium Montelukast Sodium
and Levocetirizine Eq. to Montelukast IP 4 mg
330. 29.06.2017
Hydrochloride Tablets Levocetirizine Hydrochloride
IP Excipients IP 2.5 mg
Olmisartan Medoxomil Olmisartan Medoxomil IP 10 mg
331. 29.06.2017
Esomeprazole Magnesium Trihydrate IP
Eq. to Esomeprazole 40 mg
Esomeprazole (EC) (As enteric coated pellets)
332. and Domperidone (SR) Domperidone 30 mg 29.06.2017
Capsules (As sustained release pellets)
Excipients q.s.
Esomeprazole (EC) (As enteric coated pellets)
333. and Domperidone (SR) Domperidone 30 mg 29.06.2017
Excipients q.s.
Metformin
Contains:
Hydrochloride
Sustained-release
Excipients q.s.
Tablets IP
Paroxetine Hydrochloride IP
Paroxetine
335. Eq. to Paroxetine 25 mg 29.06.2017
Excipients q.s.
336. Atenolol Tablets IP Atenolol IP 50 mg
Excipients q.s.
Sr. Ph. Approval
No. Ref. Date
Losartan Potassium Losartan potassium IP 25 mg 29.06.2017
337.
Amlodipine and
338. Metoprolol Succinate IP 29.06.2017
Metoprolol Tablets
Eq. to Metoprolol Tartrate 25 mg
Excipients q.s.
Acarbose IP 25 mg 29.06.2017
339. Acarbose Tablets
Excipients q.s.
Trihexyphenidyl
Excipients q.s.
IP
Phenytoin Sodium Phenytoin Sodium IP 100 mg
341. 29.06.2017
Ofloxacin IP 100 mg
342. Ofloxacin Tablets IP 29.06.2017
Excipients q.s.
Mirtazapine IP 15 mg 29.06.2017
343. Mirtazapine Tablets IP
Excipients q.s.
Prochlorperazine Prochlorperazine Maleate IP 25 mg
344. 29.06.2017
Maleate Tablets IP Excipients q.s.
Prochlorperazine Prochlorperazine Maleate IP 5 mg
345. 29.06.2017
Maleate Tablets IP Excipients q.s.
Olanzapine IP 20 mg
Excipients q.s.
Clozapine IP 25 mg 29.06.2017
347. Clozapine Tablets IP
Excipients q.s.
Clozapine IP 100 mg
348. Clozapine Tablets IP 29.06.2017
Excipients q.s.
Citalopram
Citalopram Hydrobromide IP
349. Hydrobromide Tablets 29.06.2017
Eq. to Citalopram 20 mg
IP
Excipients q.s.
Sr. Ph. Approval
No. Ref. Date
Fluoxetine 29.06.2017
350. Eq. to Fluoxetine 40 mg
Excipients q.s.
Dothiepin Dothiepin Hydrochloride IP 25 mg
351. 29.06.2017
352. 29.06.2017
353. Hydrochloride Tablets Eq. to Trifluoperazine 5 mg 29.06.2017
IP Excipients q.s.
Imipramine Imipramine Hydrochloride IP 75 mg
354. 29.06.2017
Amitriptyline
Excipients q.s.
IP
Trihexyphenidyl
Excipients q.s.
IP
Naproxen IP 250 mg
357. Naproxen Tablets IP 29.06.2017
Excipients q.s.
Tolperisone Tolperisone Hydrochloride IP 150 mg
358. 29.06.2017
359. Tizanidine Tablets IP Eq. to Tizanidine 2 mg 29.06.2017
Excipients q.s.
Ramipril and Ramipril IP 5 mg
Disulfiram IP 250 mg
361. Disulfiram Tablets 29.06.2017
Excipients q.s.
Each Film Coated Prolonged-released Tablet
Indapamide Prolonged-
362. Contains: 29.06.2017
released Tablets IP
Indapamide IP 1.5 mg
Sr. Ph. Approval
No. Ref. Date
Excipients q.s.
Venlafaxine Hydrochloride BP
Prolonged-released Eq. to Venlafaxine 37.5 mg
363. Venlafaxine Capsules (As Prolonged-released Pellets) 29.06.2017
BP Excipients q.s.
Venlafaxine Hydrochloride BP
Prolonged-released Eq. to Venlafaxine 75 mg
364. Venlafaxine Capsules (As Prolonged-released Pellets) 29.06.2017
BP Excipients q.s.
365. 29.06.2017
IP Excipients q.s.
Donepezil
Donepezil Hydrochloride IP 5 mg
Excipients q.s.
IP
Donepezil
Excipients q.s.
IP
Propranolol Propranolol Hydrochloride USP 40 mg
Hydrochloride (As Extended-release Pellets)
368. 29.06.2017
Extended-release Excipients q.s.
Capsules USP Colour: Approved colour used in empty
Contains:
Metoprolol Succinate
Metoprolol Succinate IP
369. Prolonged-release 29.06.2017
Eq. to Metoprolol Tartrate 12.5 mg
Tablets IP
Excipients q.s.
Etoricoxib IP 120 mg 29.06.2017
370. Etoricoxib Tablets IP
Excipients q.s.
Clozapine IP 50 mg 29.06.2017
371. Clozapine Tablets IP
Excipients q.s.
Fexofenadine
Fexofenadine Hydrochloride IP 180 mg
Excipients q.s.
IP
Velnafaxine
Velnafaxine Hydrochloride BP 29.06.2017
373. Hydrochloride Tablets
Eq. to Velnafaxine 75 mg
BP
Excipients q.s.
Sr. Ph. Approval
No. Ref. Date
Amlodipine Besylate 29.06.2017
374. Eq. to Amlodipine 2.5 mg
Tablets
Excipients q.s.
375. Mecobalamin Tablets 29.06.2017
Excipients q.s.
Amoxapine Tablets Amoxapine USP 100 mg
376. 25.07.2017
USP Excipients q.s.
Amoxapine Tablets Amoxapine USP 150 mg 25.07.2017
377.
USP Excipients q.s.
Amoxapine Tablets Amoxapine USP 50 mg
378. 25.07.2017
USP Excipients q.s.
Fluoxetine Fluoxetine Hydrochloride USP 60 mg
379. Hydrochloride Tablets Eq. to Fluoxetine q.s. 25.07.2017
USP Excipients
Loxapine Succinate USP
Loxapine Capsules Eq. to Loxapine 10 mg 25.07.2017
380.
USP Excipients q.s.
capsule shells
Loxapine Succinate USP
Loxapine Capsules Eq. to Loxapine 25 mg
381. 25.07.2017
USP Excipients q.s.
capsule shells
Thioridazine
Thioridazine Hydrochloride USP 10 mg
Excipients q.s.
USP
Doxepin Hydrochloride USP
Doxepin Hydrochloride 28.08.2017
383. Eq. to Doxepin 10 mg
Tablets
Excipients q.s.
Doxepin Hydrochloride
384. Eq. to Doxepin 25 mg 28.08.2017
Tablets
Excipients q.s.
Doxepin Hydrochloride
385. Doxepin Hydrochloride USP 28.08.2017
Tablets
Eq. to Doxepin 50 mg
Sr. Ph. Approval
No. Ref. Date
Excipients q.s.
Sodium Picosulphate Sodium Picosulphate BP 10 mg
386. 28.08.2017
Doxepin Hydrochloride Eq. to Doxepin 10 mg
387. 28.08.2017
Capsules USP Excipients q.s.
capsule shells
Doxepin Hydrochloride Eq. to Doxepin 25 mg 28.08.2017
388.
Capsules USP Excipients q.s.
capsule shells
Baclofen USP 30 mg
389. Baclofen Tablets USP 28.08.2017
Excipients q.s.
Glimepiride IP 1 mg
Glimepiride,
Eq. to Pioglitazone
Pioglitazone &
Metformin HCl (SR)
(as sustained-release)
Tablets
Excipients q.s.

Glimepiride IP 2 mg
Glimepiride,
Eq. to Pioglitazone
Pioglitazone &
Metformin HCl (SR)
(as sustained-release)
Tablets
Excipients q.s.

Serratiopeptidase IP 10 mg
(As enteric coated granules eq. to 20000 28.08.2017
392. & Serratiopeptidase
units enzymeatic activity)
Tablets
Excipients q.s.

Tofisopam 50 mg
393. Tofisopam Tablets 29.12.2017
Excipients q.s.
Tofisopam 100 mg
394. Tofisopam Tablets 29.12.2017
Excipients q.s.
Sr. Ph. Approval
No. Ref. Date
Each Film Coated Extended-release Tablet
Contains:
Etodolac Extended- 29.12.2017
395. Etodolac USP 600 mg
release Tablets USP
Excipients q.s.
Levosulpiride 25 mg
396. Levosulpiride Tablets 29.12.2017
Excipients q.s.
Levosulpiride 50 mg
397. Levosulpiride Tablets 29.12.2017
Excipients q.s.
Levosulpiride 100 mg 29.12.2017
398. Levosulpiride Tablets
Excipients q.s.
Contains:
Paroxetine Prolonged- Paroxetine Hydrocholoride IP
399. 29.12.2017
release Tablets IP Eq. to Paroxetine 25 mg
Excipients q.s.
Contains:
400. 29.12.2017
release Tablets IP Eq. to Paroxetine 37.5 mg
Excipients q.s.
Pregabalin IP 75 mg
401. Pregabalin Capsules IP Excipients q.s. 29.12.2017
capsule shells
Contains:
Quetiapine Fumarate
402. Eq. to Quetiapine 50 mg 18.01.2018
(SR) Tablets
Excipients q.s.

Contains:
Quetiapine Fumarate 18.01.2018
403. Eq. to Quetiapine 200 mg
(SR) Tablets
Excipients q.s.

Contains:
Quetiapine Fumarate Quetiapine Fumarate IP
404. 18.01.2018
(SR) Tablets Eq. to Quetiapine 300 mg
Excipients q.s.
Quetiapine Fumarate Each Uncoated Sustained-release Tablet 18.01.2018
405.
(SR) Tablets Contains:
Sr. Ph. Approval
No. Ref. Date
Eq. to Quetiapine 400 mg
Excipients q.s.
Each Uncoated Dispersible Tablet Contains:
Piroxicam Dispersible Piroxicam
406. 18.01.2018
Tablets Excipients IP 20 mg
Each Uncoated Extended-release Tablet
Contains:
Baclofen Extended-
407. Baclofen IP 30 mg 18.01.2018
release Tablets
Excipients q.s.
Contains:
408. 18.01.2018
release Tablets IP Eq. to Paroxetine 12.5 mg
Excipients q.s.
Inositol USP 100 mg
Benfotiamine 150 mg
Methylcobalamin,
Chromium Picolinate USP
409. Alpha Lipoic Acid and 18.01.2018
Eq. to Chromium 200 mcg
Vitamins Capsules
Sodium Selenite BP
Eq. to Selenium 55 mcg
Excipients q.s.
capsule shells
Each Gastro- resistant Tablet Contains:

Sodium Valproate Sodium Valproate IP 200 mg
410. Gastro- resistant Excipients q.s. 21.04.2018
Tablets IP Colour: Approved colour used
Each film Coated Controlled-release Tablet

Contains:
Sodium Valproate IP 133.5 mg
Sodium Valproate with Valproic Acid IP 58 mg
Valproic Acid Both are corresponds to Sodium Valproate 21.04.2018
411.
Controlled- release 200 mg
Each Uncoated Extended-release Tablet

Contains:
Desvenlafaxine
Desvenlafaxine Succinate IP 21.04.2018
412. Extended-release
Eq. to Desvenlafaxine 50 mg
Tablets
Excipients q.s.
Desvenlafaxine Each Uncoated Extended-release Tablet
413. 21.04.2018
Extended-release Contains:
Sr. Ph. Approval
No. Ref. Date
Tablets Desvenlafaxine Succinate IP
Eq. to Desvenlafaxine 100 mg
Excipients q.s.
Rosuvastatin and Eq. to Rosuvastatin 10 mg
414. 21.04.2018
Excipients
Vanlafaxine Hydrochloride BP
415. Venlafaxine Tablets BP Eq. to Venlafaxine 37.5 mg 21.04.2018
Excipients q.s.
Clozapine IP 25 mg
Excipients q.s.
Clozapine IP 50 mg
Excipients q.s.
Clozapine IP 100 mg
418. Clozapine Tablets IP Excipients q.s. 21.04.2018

Contains:
Propranolol
Propranolol Hydrochloride IP 20 mg
Excipients q.s.
Tablets

Pyridoxine Hydrochloride IP 3 mg
Nicotinamide IP 100 mg
Cyanocobalamin IP 15 mcg
Pyridoxine HCl, Folic Acid IP 1500 mcg
Nicotinamide, Chromium Picolinate USP 250 mcg
Cyanocobalamin, Folic (Eq. to 31.1 mcg of elemental chromium) 21.04.2018
420.
Acid, Chromium, Selenious Acid USP
Selenium and Zinc Eq. to elemental Selenium 100 mcg
Tablets Zinc Sulphate Monohydrate IP 61.8 mg
(Eq. to 22.5 mg elemental zinc)
Excipients q.s.

Telmisartan & Telmisartan 40 mg
Donepezil Each Film Coated Tablet Contains:
422. Hydrochloride & Donepezil Hydrochloride IP 5 mg 10.07.2018
Memantine Memantine Hydrochloride IP 5 mg
Sr. Ph. Approval
No. Ref. Date
Clonidine
Clonidine Hydrochloride IP 100 mcg
Excipients q.s.
IP
Baclofen IP 20 mg
Excipients q.s.
Tolperisone
Tolperisone Hydrochloride IP 150 mg
Hydrochloride & 10.07.2018
425. Diclofenac Sodium IP 50 mg
Diclofenac Sodium
Excipients q.s.
Tablets IP
Olanzapine IP 15 mg
Excipients q.s.
Each Uncoated Prolonged-release Tablet
Metformin
Contains:
Hydrochloride
Prolonged-release
Excipients q.s.
Tablets IP
Cilnidipine IP 10 mg
428. Cilnidipine Tablets IP 20.08.2018
Excipients q.s.
Ketoconazole Tablets Ketoconazole IP 200 mg 20.08.2018
429.
IP Excipients q.s.
Donepezil
Hydrochloride &
430. Memantine Hydrochloride IP 10 mg 20.08.2018
Memantine
Excipients q.s.
431. 20.08.2018
Hydrochloride Tablet IP Excipients q.s.
Each Uncoated Bilayred Tablet Contains :
Glimepiride IP 2 mg
Glimepiride & Pioglitazone Hydrochloride IP
432. Pioglitazone Eq. to Pioglitazone 15 mg 20.08.2018

Glimepiride IP 1 mg
Glimepiride &
433. Pioglitazone 20.08.2018
Eq. to Pioglitazone 15 mg
Excipients q.s.
Each Uncoated Sustained-release Tablet 20.08.2018
434. Baclofen Tablets IP
Contains:
Sr. Ph. Approval
No. Ref. Date
Baclofen IP 20 mg
Excipients q.s.
Aripiprazole IP 30 mg
435. Aripiprazole Tablets IP 20.08.2018
Excipients q.s.
Leflunomide IP 10 mg
436. Leflunomide Tablets IP 20.08.2018
Excipients q.s.
Leflunomide IP 20 mg 20.08.2018
437. Leflunomide Tablets IP
Excipients q.s.
Diacerin IP 50 mg
Diacerin, Methyl
Methyl Sulfonyl Methane USP 250 mg
438. Sulfonyl Methane & 15.09.2018
Glucosamine Sulphate Sodium Chloride IP 750 mg
Glucosamine Tablets
Excipients q.s.
Tolperisone Tolperisone Hydrochloride IP 150 mg
439. Hydrochloride & Paracetamol IP 325 mg 15.09.2018
Voglibose IP 0.3 mg
Metformin Hydrochloride IP 500 mg 15.09.2018
440. Hdrochloride (SR)
Tablets
Excipients q.s.
Methylprednisolone
441. Excipients q.s. 15.09.2018
Tablets IP

Methylprednisolone
442. Excipients q.s. 15.09.2018
Tablets IP

Excipients q.s. 15.09.2018
443. Pregabalin Capsules IP
capsule shells

Clindamycin Hydrochloride IP
Clindamycin Capsules Eq. to Clindamycin 150 mg
444. 15.09.2018
IP Excipients q.s.
capsule shells
Esomeprazole Gastro- Each Gastro-resistant Tablet Contains: 20.12.2018
445.
resistant Tablets IP Esomeprazole Magnesium Trihydrate IP
Sr. Ph. Approval
No. Ref. Date
Excipients q.s.
446. Montelukast Tablets IP Eq. to Montelukast 5 mg 20.12.2018
Excipients q.s.
Etoricoxib & Etoricoxib IP 60 mg
447. Thiocolchicoside Thiocolchicoside IP 8 mg 20.12.2018
Aripiprazole IP 5 mg 20.12.2018
448. Aripiprazole Tablets IP
Excipients q.s.
Fluvoxamine Tablets IP Fluvoxamine IP 50 mg
449. 28.01.2022
50mg Excipients q.s.
Metformin HCI (SR)
500 mg, Glimepiride 1
450. Glimepiride IP 1 mg 28.01.2022
mg & Voglibose 0.2 mg
Voglibose IP 0.2 mg
Tablets
Excipients q.s.
Metformin HCI (SR) (As Sustained-release)
500 mg, Glimepiride 2 Glimepiride IP 2 mg
451. 28.01.2022
mg & Voglibose 0.2 mg Voglibose IP 0.2 mg

Vildagliptin IP 50 mg
Vildagliptin & Metformine Hydrochloride IP 500 mg 28.01.2022
452.
Metformin HCI Tablets Excipients q.s.

Teneligliptin Hydrochloride Hydrate IP
Teneligliptin Tablets 20 Eq. to Teneligliptin 20 mg 28.01.2022
453.
mg Excipients q.s.

Trypsin BP 48 mg
Trypsin, Bromelain,
Bromelain 90 mg
Rutoside Trihydrate &
454. Rutoside Trihydrate BP 100 mg 28.01.2022
Diclofenac Sodium
Diclofenac Sodium IP 50 mg
Tablets
Excipients q.s.
455. Pantoprazole 40mg Each hard gelatin capsule contains: 16.03.2022
Sr. Ph. Approval
No. Ref. Date
(EC) & Domperidone Pantoprazole Sodium IP
10mg (IR), Eq. to Pantoprazole 40 mg
Domperidone 20mg (As enteric coated pellets)
(SR) Capsules Domperidone IP 30 mg
(10mg as immedate release pellets & 20mg
sustained release pellets)
Excipients q.s.
Eq. to Pantoprazole 40 mg
Pantoprazole (EC) & (As enteric coated pellets)
456. Levosulpride (SR) Levosulpride 75 mg 16.03.2022
Excipients q.s.
Esomeprazole (EC) & (As enteric coated pellets)
457. Levosulpiride (SR) Levosulpride 0 75 mg 16.03.2022
Excipientsp q.s.
Each uncoated tablet contains:
Aceclofenac, Aceclofenac IP 100 mg
458. Paracetamol & Paracetamol IP 325 mg 16.03.2022
Chlorzoxazone Tablets Chlorzoxazone USP 250 mg
Excipients q.s.
Diclofenac Potassium,
459. Paracetamol & 16.03.2022
Chlorzoxazone USP 250 mg
Chlorzoxazone Tablets
Excipients q.s.
Diclofenac Sodium,
Paracetamol IP 325 mg 16.03.2022
460. Paracetamol &
Chlorzoxazone Tablets
Excipients q.s.
Each 5 ml Contains:
Dextromethorphan
Dextromethorphan Hydrobromide IP 10 mg
Hydrobromide &
461. Chlorpheniramine Maleate IP 2 mg 20.08.2018
Chlorpheniramine
Flavoured Palatable Syrupy base q.s.
Maleate Syrup
Approved colour used
Each 5 ml Contains:
Phenylephrine
Phenylephrine Hydrochloride IP 5 mg
Hydrochloride,
Chlorpheniramine Maleate IP 0.5 mg
Chlorpheniramine
Maleate, Paracetamol,
Sodium Citrate IP 60 mg
Sodium Citrate &
Menthol IP 1 mg
Menthol Syrup
Sr. Ph. Approval
No. Ref. Date
Each 10 ml Contains:
Ambroxol
Ambroxol Hydrochloride IP 30 mg
Hydrochloride,
Guaiphenesin IP 100 mg
463. Guaiphenesin & 20.08.2018
Terbutaline sulphate IP 2.5 mg
Terbutaline sulphate
Syrup
Each 10 ml Contains:
Ambroxol Ambroxol Hydrochloride IP 15 mg
Hydrochloride, Guaiphenesin IP 50 mg
464. Guaiphenesin, Terbutaline sulphate IP 1.25 mg 20.08.2018
Terbutaline sulphate & Menthol 2.5 mg
Menthol Syrup Flavoured Palatable Syrupy base q.s.
Each 5 ml Contains:
Cetirizine
Cetirizine Hydrochloride IP 5 mg
Hydrochloride & 20.08.2018
465. Ambroxol Hydrochloride IP 30 mg
Ambroxol
Hydrochloride Syrup
Each 5 ml Contains:
Citicoline Sodium IP
Citicoline Sodium & Eq. to Citicoline 500 mg
466. 20.08.2018
Piracetam Syrup Piracetam IP 400 mg
Flavoured Palatable Syrupy base
Composition:
Chlorhexidine Chlorhexidine Gluconate Solution IP 0.20 %w/v
467. Gluconate mouth wash Diluted to Chlorhexidine Gluconate q.s. 20.08.2018
IP Flavoured Base
Colour Brillient Blue
Each 5 ml contains:
Cyproheptadine Hydrochloride IP 2 mg
Cyproheptadine Tricholine Citrate 275 mg
468. Hydrochloride & Sorbitol Solution (70%) IP q.s. 20.08.2018
Tricholine Citrate Syrup (Non-Crystallising)
In Flavoured Base
Each 5 ml Contains:
Ferrous Ascorbate IP
Ferrous Ascorbate &
469. Eq. to elemental Iron 30 mg 20.08.2018
Folic Acid Suspension
Folic Acid 550 mcg
Flavoured Palatable Base q.s.
Each 5 ml Contains:
Montelukast Sodium &
Eq. to Montelukast 4 mg 20.08.2018
470. Levocetrizine
Levoceitrizine Dihydrochloride IP 2.5 mg
Dihydrochloride Syrup
Flavoured Palatable Syrupy Base q.s.
Each 5 ml Contains:
Magaldrate &
Magaldrate IP 480 mg
471. Simethicone Oral 20.08.2018
Simethicone IP 20 mg
suspension USP
Liquid Paraffin, Milk of Each 5 ml contains:
Magnesia & Sodium Liquid Paraffin IP 1.25 mg
472. 15.09.2018
Picosulphate Milk of Magnesia IP 3.75 mg
Suspension Sodium Picosulphate BP 3.33 mg
Sr. Ph. Approval
No. Ref. Date
Each 5 ml contains:
Dried Aluminium Dried Aluminium Hydroxide IP 250 mg
Hydroxide, Activated Activated Dimethicone (30%) IP 50 mg
473. Dimethicone, Magnesium Hydroxide IP 250 mg 15.09.2018
Magnesium Hydroxide Sorbitol (70%) (Non crystallizing) 1.25 gm
Suspension Flavoured Palatable Base q.s.
Each 5 ml contains:
Dried Aluminium
Dried Aluminium Hydroxide Gel IP 600 mg
Hydroxide Gel,
Magnesium Hydroxide IP 300 mg
Magnesium Hydroxide,
474. Simethicone IP 25 mg 15.09.2018
Simethicone,
Oxetacaine BP 10 mg
Oxetacaine
Suspension
Composition :
Ketoconazole & Zinc Ketoconazole IP 2 %w/w
475. 15.09.2018
Pyrithione Lotion Zinc Pyrithione 1 %w/v
Base q.s.
Each 5 ml contains:
Ofloxacin Oral Ofloxacin IP 50 mg
476. 20.12.2018
Suspension IP Flavoured Palatable Base q.s.
Each 5 ml contains:
Ondansetron Hydrochloride IP
Ondansetron Oral
477. Eq. to Ondansetron 4 mg 20.12.2018
Solution IP
Each 5 ml contains:
Paracetamol Syrup IP Paracetamol IP 125 mg
478. 20.12.2018
(For Paediatric use) Flavoured Palatable Base q.s.
Each 5 ml contains:
Promethazine Hydrochloride IP 5 mg
479. Promethazine Syrup IP 20.12.2018
Each 5 ml contains:
Sodium Picosulfate Sodium Picosulfate BP 5 mg
480. 20.12.2018
Oral Supension BP Flavoured Palatable Base q.s.
Each 5 ml contains:
Sodium Valproate Oral Sodium Valproate IP 200 mg 20.12.2018
481.
Solution IP Flavoured Palatable Base q.s.
Each 5 ml contains:
Albendazole Oral Albendazole IP 200 mg 20.12.2018
482.
suspension IP Flavoured Palatable Base q.s.
Each 5 ml contains:
Lactulose Solution USP
Lactulose Solution
483. Eq. to Lactulose 3.335 gm 20.12.2018
USP
Flavoured Base q.s.
Povidone - Iodine Composition: 20.12.2018
484.
Solution IP Povidone Iodine IP 5 %w/v
Sr. Ph. Approval
No. Ref. Date
(For external use ) (Available Iodine 0.5% w/v)
Purified water IP q.s.
Each 5 ml contains:
Levosalbutamol Sulphate IP
Levosalbutamol
Equivalent to Levosalbutamol 1 mg
Sulphate, Ambroxol 28.01.2022
485. Ambroxol Hydrochloride IP 30 mg
Hydrochloride &
Guaihenesin IP 50 mg
Guaihenesin Syrup
Flavoured base q.s.
Each 5 ml contains:
Disodium Hydrogen Citrate BP 0.335 g
Disodium Hydrogen 16.03.2022
486. Excipients q.s.
Citrate Syrup
In a flavoured base
Each 5 ml contains:
Cyproheptadine Hydrochloride IP 2 mg
Cyproheptadine Tricholine Citrate (65%) 275 mg
487. Hydrochloride & Sorbitol Solution (70%) IP q.s. 16.03.2022
Tricholine Citrate Syrup (Non-Crystallising)
Each 5 ml contains:
Ivermectin IP 1.5 mg
Albendazole &
488. Albendazole IP 200 mg 16.03.2022
Ivermectin Suspension
In a flavoured syrup base q.s.
Beclomethasone Composition:
Dipropionate & Beclomethasone Dipropionate IP 0.025% w/w
489. 20.08.2018
Neomycin Sulphate Neomycin sulphate IP 0.50% w/w
Cream In cream base
Composition:
Mometasone Furorate
Mometasone furorate IP 0.10% w/w 20.08.2018
490. & TerbInafine
Terbinafine Hydrochloride IP 1.00% w/w
Hydrochloride Cream
In cream base
Composition:
Mometasone Furoate Mometasone furorate IP 0.10% w/w
491. 20.08.2018
& Salicylic Acid Cream Salicylic Acid IP 5.00% w/w
In cream base
Composition:
Adapalene & Adapalene USP 1 mg
492. Clindamycin Clindamycin Phosphate IP 10 mg 20.08.2018
Phosphate Gel Eq. to Clindamycin
In gel base
Composition:
Sucralfate IP 7.00% w/w
Sucralfate & Povidone 20.08.2018
493. Povidone Iodine IP 5.00% w/w
Iodine Ointment
(Available Iodine 0.5%w/w)
Ointment base
Beclomethasone Each gm Contains:
Dipropionate, Beclomethasone Dipropionate IP 0.25 mg
494. Econazole & Econazole IP 10 mg 20.08.2018
Neomycin Sulphate Neomycin Sulphate IP 5 mg
Cream In cream base
Hydroquinone, Each gm Contains:
495. Tretinone & Hydroquinone IP 20 mg 20.08.2018
Fluocinolone Tretinoin USP 0.25 mg
Sr. Ph. Approval
No. Ref. Date
Acetonide Cream Fluocinolone Acetonide IP 0.1 mg
In cream base
Composition:
Hydroquinone, Hydroquinone IP 2.00% w/w
496. Tretinoin & Allantoin Tretinoin USP 0.025% w/w 20.08.2018
Gel Allantoin IP 1.00% w/w
In gel base
Each gm Contains:
497. Tretinoin & Tretinoin USP 0.05% w/w 20.08.2018
Hydrocortisone Cream Fluocinolone Acetonide IP 1.00% w/w
In cream base
Composition:
Clindamycin Phosphate IP
Clindamycin &
Eq. to Clindamycin 1.00% w/w 20.08.2018
498. Hydrous Benzoyl
Hydrous Benzoyl Peroxide IP
Peroxide Gel
Eq. to Anhydrous Benzoyl Peroxide 2.50% w/w
In gel base
Composition:
Ornidazole IP 1% w/w
Ornidazole & Povidone
499. Povidone Iodine IP 20.08.2018
Iodine Ointment
(As 0.5% w/w Available Iodine ) 5% w/w
In ointment base
Composition:
Tretinoin & Tretinoin USP 0.025% w/w
500. 20.08.2018
Mometasone Furoate Mometasone Furoate IP 0.10% w/w
Gel In gel base
Composition:
Mometasone Furoate IP 0.10% w/w
Mometasone Furoate 20.08.2018
501. Fusidic Acid IP 2% w/w
& Fusidic acid Cream
In cream base
Contains:
Diclofenac Diethylamine IP 1.16% w/w
Eq. to Diclofenac Sodium 1% w/w
Diclofenac Linseed Oil BP 3.00% w/w
Diethylamine, Linseed Methyl Salicylate IP 10% w/w 20.08.2018
502.
Oil, Methyl Salicylate & Menthol IP 5% w/w
Menthol Gel Benzyl Alcohol IP 1% w/w
(As Preservative)
Gel base
Composition:
Silver Sulphadiazine 20.08.2018
503. Silver Sulphadiazine IP 1.00% w/w
Cream IP
In cream base
Composition:
Povidone Iodine Povidone Iodine IP 5.00% w/w
504. 20.08.2018
Ointment USP (As available Iodine 0.5% w/w)
Water soluble ointment base q.s.
Each gm Contains:
Sucralfate Povidone Sucralfate IP 70 mg
505. Iodine & Metronidazole Metronidazole IP 10 mg 20.08.2018
Ointment Povidone Iodine IP 50 mg
Water soluble ointment base
Sr. Ph. Approval
No. Ref. Date
Itraconazole USP 1.00% w/w
Itraconazole, Ofloxacin IP 0.75% w/w
Ofloxacin, Ornidazole Ornidazole IP 2.00% w/w 28.01.2022
506.
& Clobetasole Clobetasole Propionate IP 0.05% w/w
Propionate Cream Methyl Paraden (Preservative) IP 0.16% w/w
Propyl Praden (Preservative) IP 0.033% w/w
Gamma Benzene Hexachloride IP 1 % w/v
Gamma Benzene Cetrimide IP 0.1 % w/v 16.03.2022
507. Hexachloride & In an emulsion base q.s.
Cetrimide Lotion
Each 270 mg of Pellets Contains:

Pantoprazole(EC) &
(As enteric coated pellets) 10.01.2019
508. Domperidone (SR)
Pellets
(As sustained-release pellets)
Excipient q.s.
Colour : Approved colour used
Each gram of Pellets Contains:
Rabeprazole Sodium
Enteric Coated Pellets 10.01.2019
509. (As enteric coated pellets)
15.4% w/w
Excipient q.s.
Pellets
Pantoprazole(EC) &
510. Domperidone (IR)
Pellets
(As Immediate release pellets)
Excipient q.s.
Pantoprazole(EC) & (As enteric coated pellets)
Domperidone (SR & Domperidone IP 10 mg 10.01.2019
511.
IR) (As sustained-release pellets)
Pellets Domperidone IP 10 mg
(As Immediate release pellets)
Excipient q.s.
Pantoprazole(EC) &
512. Itopride (SR)
Itopride Hydrochloride 150 mg
Pellets
Excipient q.s.
Pantoprazole(EC) & Eq. to Pantoprazole 40 mg
10.01.2019
513. Levosulpiride (SR) (As enteric coated pellets)
Pellets Levosulpiride IP 75 mg
Excipient q.s.
Sr. Ph. Approval
No. Ref. Date

Omeprazole IP 20 mg
Omeprazole (EC) & (As enteric coated pellets)
10.01.2019
514. Domperidone (SR) Domperidone IP 30 mg
Pellets (As sustained-release pellets)
Excipient q.s.
Omeprazole IP 20 mg
Omeprazole (EC) & (As enteric coated pellets)
10.01.2019
515. Domperidone (IR) Domperidone IP 10 mg
Pellets (As immediate release pellets)
Excipient q.s.
Rabeprazole Sodium
(EC) & Levosulpiride 10.01.2019
516. Levosulpiride IP 75 mg
(SR)
Pellets
Excipient q.s.
Rabeprazole Sodium
(EC) & Itopride 10.01.2019
517. Itopride Hydrochloride 150 mg
Hydrochloride (SR)
Pellets
Excipient q.s.
Rabeprazole Sodium
(EC) & Domperidone 10.01.2019
518. Domperidone IP 30 mg
(SR)
Pellets
Excipient q.s.
Dexrabeprazole Sodium IP 10 mg
Dexrabeprazole
Sodium (EC) & 10.01.2019
519. Domperidone IP 30 mg
Domperidone (SR)
Pellets
Excipient q.s.
Rabeprazole Sodium
(EC) & Aceclofenac 10.01.2019
520. Aceclofenac IP 200 mg
(SR)
Pellets
Excipient q.s.
Sr. Ph. Approval
No. Ref. Date
Rabeprazole Sodium
(EC) & Diclofenac 10.01.2019
521. Diclofenac Sodium IP 100 mg
Sodium (SR)
Pellets
Excipient q.s.
Esomeprazole (EC) &
522. Levosulpiride (SR)
Levosulpiride IP 75 mg
Pellets
Excipient q.s.
Esomeprazole (EC) &
523. Domperidone (SR)
Pellets
Excipient q.s.
Esomeprazole (EC) & Eq. to Esomeprazole 40 mg
Itopride Hydrochloride (As enteric coated pellets) 10.01.2019
524.
(SR) Itopride Hydrochloride 150 mg
Excipient q.s.
Flunazine Dihydrochloride BP
Flunazine & Eq. to Flunazine 5 mg
Propranolol (As pellets) 10.01.2019
525.
Hydrochloride (SR) Propranolol Hydrochloride IP 40 mg
Excipient q.s.
Flunazine Dihydrochloride BP
Flunazine & Eq. to Flunazine 10 mg
Propranolol (As pellets) 10.01.2019
526.
Hydrochloride (SR) Propranolol Hydrochloride IP 40 mg
Excipient q.s.
Each 266.66 mg of Pellets Contains:
Omeprazole IP 20 mg
Omeprazole IP (EC) 10.01.2019
527. (As enteric coated pellets) q.s.
Pellets
Excipient
Omeprazole IP (EC) Omeprazole IP 20 mg 10.01.2019
Pellets
Excipient
Sr. Ph. Approval
No. Ref. Date

Omeprazole IP 20 mg
Pellets
Excipient
Omeprazole IP 20 mg
Pellets
Excipient
Each gram of Pellets Contains:
Itraconazole BP Itraconazole Pellets BP 400 mg 10.01.2019
531. Excipient q.s.
Pellets 40%w/w
Colour : Titanium Dioxide IP
Itraconazole BP Itraconazole BP 100 mg
532. Excipient q.s. 28.01.2022
(Pellets)
533. Excipient q.s. 28.01.2022
(Pellets)
534. Excipient q.s. 28.01.2022
(Pellets)
Lansoprazole IP 30 mg
Lansoprazole IP 28.01.2022
535. (As Enteric Coated Pellets) q.s.
(Pellets)
Excipient
Lansoprazole IP 30 mg
Lansoprazole IP 28.01.2022
536. (As Enteric Coated Pellets) q.s.
(Pellets)
Excipient
Itraconazole USP Itraconazole USP 100 mg
537. Excipient q.s. 28.01.2022
(Pellets)
Itraconazole USP Itraconazole USP 100 mg
538. Excipient q.s. 28.01.2022
(Pellets)
Each uncoated bilayered tablet contains:
Nimesulide &
Paracetamol Tablets
Excipients q.s.
Sr. Ph. Approval
No. Ref. Date
Each film coated tablet contains:
Calcium Citrate USP 1000 mg
Calcium Citrate,
Vitamin D3 IP 200 IU
Vitamin D3,
Magnesium Hydroxide IP 100 mg
540. Magnesium Hydroxide 08.06.2022
& Zinc Sulphate
Eq. to Elemental Zinc 4 mg
Tablets
Excipients q.s.
Each enteric coated tablet contains:
Pantoprazole & (As enteric coated tablet) 08.06.2022
541.
Domperidone Tabletss Domperidone IP 10 mg
(As sustained release form)
Excipients q.s.
Vildagliptin IP 50 mg
542. Vildagliptin Tablets Excipients q.s. 08.06.2022

Sildenafil Citrate IP 50 mg
Depoxetine Hydrochloride IP
Sildenafil &
545. Eq. Depoxetine 30 mg 08.08.2022
Depoxetine Tablets
Excipients q.s.

Glimepiride IP 1 mg
Glimepiride,
Eq. to Pioglitazone
Pioglitazone &
Metformin HCl (ER)
Tablets
Excipients q.s.

Glimepiride IP 2 mg
Glimepiride,
Eq. to Pioglitazone
Pioglitazone &
Metformin HCl (ER)
Tablets
Excipients q.s.

Diclofenac Sodium &
548. Paracetamol Tablets 08.08.2022
Excipients q.s.
IP

Flavoxate
Flavoxate Hydrochloride IP 200 mg
Excipients q.s.
IP 200 mg
550. Fexofenadine Each film coated tablet contains: 08.08.2022
Sr. Ph. Approval
No. Ref. Date
Hydrochloride Tablets Fexofenadine Hydrochloride IP 120 mg
IP 120 mg Excipients q.s.

Esomeprazole Gastro-
551. (As enteric coated pellets) 08.08.2022
resistant Capsules IP
Excipients q.s.
Doxylamine Succinate USP 10 mg
Doxylamine Succinate
552. & Pyridoxine 08.08.2022
Excipients q.s.
(Appropriate overages of vitamins added)
Sitagliptin Phosphate Monohydrate IP 50 mg
Sitagliptin Phosphate
553. Eq. to Sitagliptin Phosphate q.s. 08.08.2022
Tablets IP 50 mg
Excipients
Sitagliptin Phosphate Monohydrate IP
Sitagliptin Phosphate
554. Eq. to Sitagliptin Phosphate 100 mg 08.08.2022
Tablets IP 100 mg
Excipients q.s.
Each uncoated bilayered tablet contains:
Nimesulide & Paracetamol IP 325 mg
556. 01.11.2022

Azithromycin and Eq. to Anhydrous Azithromycin 500 mg
557. Lactic Acid Bacillus Lactic Acid Bacillus 60 million 01.11.2022
Tablets Excipients Spores
Colour: Approved colour used0 q.s.

Azithromycin and Eq. to Anhydrous Azithromycin 250 mg
558. Lactic Acid Bacillus Lactic Acid Bacillus 60 million 01.11.2022
Tablets Excipients Spores

Doxylamine Succinate USP 10 mg
Doxylamine Succinate,
Pyridoxine
Folic Acid IP 2.5 mg 01.11.2022
Hydrochloride & Folic
Excipients q.s.
Acid Tablets
(Appropriate overages of vitamins added)
Aceclofenac, Each Film coated tablet contains: 01.11.2022
Paracetamol & Aceclofenac IP 100 mg
Sr. Ph. Approval
No. Ref. Date
Chlorzoxazone Tablets Paracetamol IP 325 mg
Excipients q.s.
Each uncoated Tablet contains:
Gliclazide Tablets IP Gliclazide IP 80 mg 01.11.2022
Excipients q.s.
Drotaverine
Drotaverine Hydrochloride IP 80 mg
Hydrochloride &
Mefenamic Acid IP 250 mg 01.11.2022
Mefenamic Acid
Excipients q.s.
Tablets IP
Dicyclomine
Dicyclomine Hydrochloride IP 20 mg
559. Hydrochloride & 02.03.2023
Paracetamol Tablets
q.s.
Each 5ml Contains
Aceclofenac & Aceclofenac IP 50 mg
560. Paracetamol Paracetamol IP 125 mg q.s. 02.03.2023
Suspension Flavour Syrupy Base
Colour: Approved Colour used
Citicoline Sodium IP 500 mg
Citicoline Sodium & Eq. to Citicoline
563. 20.03.2023
Piracetam Tablets Piracetam IP 800 mg
Excipients q.s.
Each 15 ml contains:
Lactulose Solution Lactulose Concentrate USP
564. 20.03.2023
USP Eq. to Lactulose (66%) 10 gm
Palatable Base q.s.
Proguanil Each Uncoated Tablet Contains:
561. Hydrochloride Tablet Proguanil Hydrochloride IP 100 mg 28.03.2023
IP Excipients q.s.

MBC APPROVALpdf

Uploaded by

Copyright:

Available Formats

You might also like

MBC APPROVALpdf

Uploaded by

Document Information

Original Description:

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

MBC APPROVALpdf

Uploaded by

Copyright:

Available Formats

M/S MBC INDUSTRIES, TRILOKPUR ROAD, KALA-AMB, TEHSIL- NAHAN, DISTT-SIRMOUR (HP) 173030 UNDER

Each Uncoated Tablets Contains:

Each Enteric Coated Tablets Contains:

Each Film Coated Tablets Contains:

Each Film Coated Tablets Contains:

Each Film Coated Tablets Contains:

Each Film Coated Tablets Contains:

Each Uncoated Tablets Contains:

Each Enteric Coated Tablets Contains:

Each Uncoated Bilayered Tablets Contains:

Each Hard Gelatin Capsule Contains:

Each Hard Gelatin Capsule Contains:

Each Hard Gelatin Capsule Contains:

Each Film Coated Tablets Contains:

Each Hard Gelatin Capsule Contains:

Each Uncoated Dispersible Tablets Contains:

Each Film Coated Tablets Contains:

Each Film Coated Tablets Contains:

Each Uncoated Tablets Contains:

Each Uncoated Tablets Contains:

Each Uncoated Tablets Contains:

153. Omeprazole Gastro- Each hard gelatin capsule contains: 25.05.2017

164. Olmesartan Medoxomil Each Film Coated Tablets Contains: 25.05.2017

Each Film Coated Tablet Contains:

Each Film Coated Tablet Contains:

Each Film Coated Tablet Contains:

191. Amlodipine and Each Film Coated Tablet Contains: 27.05.2017

Each Film Coated Tablet Contains:

Each Film Coated Tablet Contains:

Each Film Coated Tablet Contains:

199. Amlodipine and Each Uncoated Tablet Contains: 27.05.2017

Each Film Coated Tablet Contains:

Each Film Coated Tablet Contains:

Each Gastro-resistant Tablet Contains:

Each Uncoated Tablet Contains:

Each Uncoated Tablet Contains:

Each Film Coated Tablet Contains:

Each Film Coated Tablet Contains:

Each Film Coated Tablet Contains:

Each hard gelatin capsule contains:

Each hard gelatin capsule contains:

Each hard gelatin capsule contains:

Methylcobalamin, Each hard gelatin capsule contains:

Each Film Coated Tablet Contains:

Each Film Coated Tablet Contains:

Each Film Coated Tablet Contains:

Each Uncoated Sustained-release Tablet

Each Uncoated chewable Tablet Contains:

Each Film Coated Tablet Contains:

Each Film Coated Tablet Contains:

Each Film Coated Tablet Contains:

Each Film Coated Tablet Contains:

Each Film Coated Tablet Contains:

Each Uncoated Extended-releaseTablet

Each Uncoated Bilayered Tablets Contains:

Each Film Coated Tablet Contains:

Each Uncoated Bilayered Tablets Contains:

Each Film Coated Tablet Contains: